Spectral Reflectometric Microscopy on Myelinated Axons In Situ
July 2nd, 2018
6.9K views
Here, we present a step-by-step protocol for imaging myelinated axons in a fixed brain slice using a label-free nanoscale imaging technique based on spectral reflectometry.
Overview
This article presents a detailed protocol for spectral reflectometry (SpeRe), a novel, label-free imaging technique that enables nanoscale analysis of myelinated axons in live or fixed nervous tissue. By analyzing the reflectance spectrum of multilayered myelin structures, SpeRe provides quantitative nanostructural information without the need for complex labeling or extensive sample preparation. The protocol covers sample preparation, spectral data acquisition using a confocal microscope with a white-light laser and tunable filter, and image processing steps for extracting axonal nanostructure.
Key Study Components
Area of Science
- Neuroscience
- Optical imaging
- Myelin biology
Background
- Myelin sheaths provide electrical insulation for axons in the mammalian nervous system.
- Traditional imaging of myelin nanostructure often requires labeling and complex sample preparation.
- SpeRe is inspired by the organized architecture of myelin and leverages optical reflectance for label-free imaging.
- Understanding myelin structure is crucial for studying myelin plasticity and demyelination.
Purpose of Study
- To provide a step-by-step protocol for performing SpeRe imaging on nervous tissue.
- To demonstrate label-free, nanoscale imaging of myelinated axons in situ.
- To validate SpeRe measurements against conventional fluorescence-based methods.
Methods Used
- Preparation of fixed mouse brain slices and mounting between glass slides with spacers.
- Sealing samples with nail polish to prevent evaporation and contamination.
- Acquisition of spectral reflectance data using a confocal microscope equipped with a white-light laser and tunable filter.
- Calibration using a reference mirror and dark reference acquisition.
- Image processing in ImageJ to extract and normalize reflectance spectra from regions of interest.
- Conversion of spectral data to axon diameter using mathematical fitting and normalization procedures.
Main Results
- SpeRe enables label-free, nanoscale imaging of myelinated axons in intact brain tissue.
- The technique provides axon diameter measurements that agree with fluorescence-based methods.
- SpeRe imaging requires lower light doses than conventional fluorescence confocal microscopy.
- Optimal imaging depth is greater than 15 micrometers from the coverslip to minimize background noise.
Conclusions
- SpeRe is a powerful, label-free method for nanoscale imaging of myelinated axons.
- The protocol is accessible and can be performed with standard confocal microscopy equipment.
- This technique facilitates studies of myelin structure, plasticity, and pathology in both fixed and potentially live tissues.
Frequently Asked Questions
What is spectral reflectometry (SpeRe)?
SpeRe is an imaging technique that analyzes the reflectance spectrum of multilayered myelin to obtain nanostructural information about myelinated axons without the need for labeling.
What are the main advantages of SpeRe over traditional imaging methods?
SpeRe allows label-free, nanoscale imaging of myelinated axons in intact tissue, requires less complex sample preparation, and uses lower light doses compared to fluorescence-based methods.
How is the sample prepared for SpeRe imaging?
Fixed brain slices are mounted between glass slides with spacers, covered with PBS, sealed with a cover glass, and secured with nail polish to prevent evaporation and contamination.
What equipment is required for SpeRe imaging?
A commercial confocal microscope equipped with a white-light laser, tunable filter, and a high numerical aperture water-immersion objective lens is used for SpeRe imaging.
How is the axon diameter determined using SpeRe?
The reflectance spectrum from axon segments is analyzed, normalized, and mathematically fitted to extract wavenumber periodicity, which is then converted to axon diameter using a specific equation.
How does SpeRe compare to fluorescence-based measurements?
SpeRe-derived axon diameters are in good agreement with those obtained from fluorescence-based imaging, validating the accuracy of the technique.
What are important considerations for minimizing background noise in SpeRe?
Imaging should be performed at depths greater than 15 micrometers from the coverslip to avoid significant background noise from the silica-based coverslip.
Executive Industry Relevance
Spectral reflectometric microscopy (SpeRe) enables label-free, nanoscale imaging of myelinated axons directly in intact nervous tissue, providing quantitative nanostructural data critical for early neurobiology discovery. This capability supports mechanistic de-risking and target validation in neurodegeneration and demyelination research, enhancing predictive confidence at key inflection points in CNS drug discovery. By eliminating complex labeling and reducing light exposure, SpeRe streamlines workflows and increases throughput for translational neuroscience portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of myelin nanostructure in situ for mechanistic studies.
- Supports functional target validation by quantifying axonal and myelin integrity without exogenous labels.
- Facilitates predictive confidence in early-stage CNS target selection and triage.
Screening & Assay Development
- Prepares validated, label-free biological systems for downstream compound screening.
- Delivers quantitative, reproducible measurements of axon diameter and myelin structure.
- Reduces assay complexity and increases scalability for high-content imaging platforms.
Translational & Preclinical Research
- Aligns nanoscale imaging outputs with disease-relevant models of demyelination and plasticity.
- Enables continuity from discovery through preclinical validation by providing robust, quantitative endpoints.
- Supports risk-adjusted advancement decisions in neurodegenerative disease pipelines.
Pipeline & Workflow Integration
SpeRe integrates into the discovery-to-preclinical continuum by providing quantitative nanostructural readouts for hypothesis testing, target validation, and translational biomarker development in CNS research.
- Discovery Biology: Supports hypothesis-driven interrogation of myelin and axonal architecture in intact tissue.
- Screening: Provides reproducible, quantitative imaging outputs suitable for assay standardization.
- Analytics: Enables extraction of axon diameter and myelin periodicity for comparative analysis across conditions.
- Translational Research: Bridges discovery and preclinical studies by aligning imaging outputs with disease models.
- Enterprise Reuse: Offers a reusable, label-free imaging capability for diverse neurobiology programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in CNS target validation.
- Operational Value: Streamlines workflows through label-free imaging and reduced sample preparation.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing robust, quantitative endpoints.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of neurodegenerative disease assets.
Implementation Considerations
- Requires expertise in confocal microscopy and spectral data analysis.
- Needs access to a confocal microscope with a white-light laser and tunable filter.
- Demands cross-team standardization of imaging depth and data normalization procedures.
- Adaptation may be needed for different tissue types or live animal imaging.
- Imaging depth must exceed 15 micrometers from the coverslip to minimize background noise.
Biopharma FAQs
Why is null hypothesis testing critical for SpeRe-based target validation?
Null hypothesis testing using SpeRe-derived nanostructural data enables objective assessment of myelin integrity differences between experimental groups, supporting robust target validation in CNS discovery. This quantitative approach reduces bias and increases confidence in mechanistic findings relevant to neurodegeneration pipelines.
How does independent variable isolation in spectral acquisition fit the discovery pipeline?
Isolating variables such as imaging depth and region of interest during spectral acquisition ensures that observed nanostructural changes are attributable to experimental manipulations, strengthening mechanistic de-risking and supporting early-stage decision-making in neurobiology R&D.
What do quantitative axon diameter measurements enable in CNS research?
Quantitative axon diameter outputs from SpeRe provide reproducible endpoints for comparing disease models, evaluating compound effects, and aligning with translational biomarkers, thereby enhancing predictive confidence across the discovery-to-preclinical continuum.
Why do replication requirements matter for cross-functional imaging workflows?
Replication of SpeRe imaging across multiple tissue samples and experimental runs ensures data reliability, facilitates cross-team standardization, and supports collaborative decision-making in multi-disciplinary CNS research programs.
What statistical analysis capabilities are required before implementing SpeRe imaging?
Robust statistical analysis of spectral and diameter data—including normalization, baseline correction, and comparative testing—is essential to validate findings and enable integration of SpeRe outputs into enterprise-level R&D workflows.
